A radiation device placed inside the tumor for glioblastoma that has come back
Original title: Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study does not list a phase, so it is still a test and not care you can get from your own doctor.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a small device that gives off radiation from inside a brain tumor that has returned.
Who this trial is for. This trial is for people whose glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary has come back. It is testing a device that is placed inside the tumor and gives off a kind of radiation called alpha radiation.
Where it stands. This trial has not reported results. It is looking at how this device works as a treatment for glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary that has come back. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If your glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary has come back, this is one more idea being tested. You could ask your care team about it. They can tell you if a trial like this makes sense for your situation, and what your other choices are.
What it doesn't mean: This does not mean the device works. A trial is a test, not a proven treatment. Joining one is not a guarantee that you will be helped. It is not a promise of a cure. And no one can promise you a spot. The trial team decides who can join.
Source: ClinicalTrials.gov, July 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.